Drug profile · INN
nafarelin
SYNAREL
nafarelin (SYNAREL) is a gonadotropin-releasing hormone receptor agonist. Associated with Pfizer Australia Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — nafarelin
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
nafarelin (SYNAREL) is a gonadotropin-releasing hormone receptor agonist. Associated with Pfizer Australia Pty Ltd.
Key facts
INN nafarelin
Brand SYNAREL
Mechanism Gonadotropin-releasing hormone receptor agonist
Originator Pfizer Australia Pty Ltd
Mechanism of action
Gonadotropin-releasing hormone receptor agonist
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is nafarelin?
nafarelin (SYNAREL) is a gonadotropin-releasing hormone receptor agonist. Associated with Pfizer Australia Pty Ltd.
What is the brand name for nafarelin?
SYNAREL is a marketed brand name for nafarelin. Check FDA Drugs@FDA for the current US label holder and prescribing information.